| Family: | Direxion Shares |
| Name: | Direxion Daily S&P Biotech Bull 3x Shares |
| Inception Date: | 28-May-2015 |
| Termination Date: | |
| Investment Objective: | The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015. |
| Prospectus | |
| Top 10 Holdings | ||
| Derivatives offset | -233.7837% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 89.1470% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 62.9319% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 36.0097% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 21.7484% | |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | X9USDGLDS | 16.0091% |
| GOLDMAN FINL SQ TRSRY INST 506 | 12.7703% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 12.5489% | |
| DREYFUS GOVT CASH MAN INS | 12.4122% | |
| S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP | 8.4168% | |
| Top 10 Holdings Weight: | 38.2% |
| Number of Holdings: | 162 |
| Shares Outstanding: | 4,074,486 |
| Total Net Assets: | 673,553,300 |
| NAV: | 165.55 |
| Net Expense Ratio: | 0.93% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Biotech |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | Leveraged (3x) |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
